Medigen Biotechnology Corp. (TPEX:3176)
Taiwan
· Delayed Price · Currency is TWD 28.90
+0.20 (0.70%)
Apr 24, 2025, 1:30 PM CST
Medigen Biotechnology Revenue
In the year 2024, Medigen Biotechnology had annual revenue of 1.37B TWD with 18.57% growth. Medigen Biotechnology had revenue of 330.64M in the quarter ending December 31, 2024, a decrease of -10.88%.
Revenue
1.37B
Revenue Growth
+18.57%
P/S Ratio
2.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.37B | 214.98M | 18.57% |
| Dec 31, 2023 | 1.16B | 101.77M | 9.64% |
| Dec 31, 2022 | 1.06B | -2.87B | -73.08% |
| Dec 31, 2021 | 3.92B | 3.31B | 537.17% |
| Dec 31, 2020 | 615.54M | 63.20M | 11.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |